期刊文献+

他汀类药物对糖尿病性骨质疏松患者骨钙素和骨密度影响的系统评价 被引量:13

The effect of statins on BGP and BMD of diabetic osteoporosis patients: A systematic review
下载PDF
导出
摘要 目的系统评价他汀类药物对糖尿病性骨质疏松患者骨钙素和骨密度的影响。方法计算机检索Cochrane、pubmed、EMbase、CBM、CNKI,检索时间为从建库至2011年8月。评价质量及提取资料后,采用RevMan 5.1软件对数据进行Meta分析。结果纳入随机对照试验的文献数7篇,共453例,Meta结果显示,对骨钙素的影响[MD=0.26,95%CI(0.06,0.46)],腰椎骨密度的影响[MD=0.22,95%CI(0.05,0.40)],股骨颈骨密度的影响[MD=0.04,95%CI(-0.05,0.13)],Wards三角区骨密度的影响[MD=0.06,95%CI(0.02,0.09)],大转子骨密度的影响[MD=0.03,95%CI(-0.00,0.07)],髋骨骨密度的影响[MD=0.02,95%CI(-0.02,0.07)]。结论他汀类药物对糖尿病性骨质疏松患者的治疗还是有一定的疗效,但由于文献质量方面不太理想,尚需更多高质量的随机对照试验提供依据。 Objective To systematically evaluate the effect of statins on bone gla protein(BGP) and bone mineral density(BMD) of diabetic osteoporosis(DOP) patients.Methods PubMed,EMbase,Cochrane,CBM,and CNKI database were researched.The time for research was from the beginning of database establishment to August 2011.The Meta analysis was performed using RevMan 5.1 software after the quantity evaluation and obtaining the materials.Results Seven papers of randomized controlled trial involving 453 patients were included.The influences on BGP,BMD of the lumbar spine,femoral neck,Ward's triangle,trochanter,and total hip were showed by Meta-analysis,respectively.Conclusion Statins have definite efficacy for the treatment of DOP.However,due to unsatisfied paper quality,more RCTs with high quality are needed.
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2012年第3期263-268,共6页 Chinese Journal of Osteoporosis
基金 广东省自然科学基金(7009932)
关键词 他汀类药物 糖尿病 骨质疏松 meta分析 Statins Diabetes Osteoporosis Meta-analysis
  • 相关文献

参考文献16

二级参考文献34

  • 1周连华,周湘兰,施晓红.糖尿病患者合并骨质疏松症的多因素分析[J].中国临床康复,2004,8(24):5074-5075. 被引量:11
  • 2张龙,张柳.骨质疏松症药物治疗的研究进展[J].华北煤炭医学院学报,2005,7(4):452-454. 被引量:9
  • 3薛延.骨质疏松症的流行病学概况[J].新医学,2007,38(1):7-8. 被引量:71
  • 4[1]Mundy G,Garrett K,Harris S,et al.Stimulation of bone formation in vitro and in rodents by statins.Science,1999,286:1946-1949.
  • 5[2]Kanis JA,Melton LJ,Chrestiansen C,et al.The dignosis of osteoporosis.J Bone Miner Res,1994,9:1137-1139.
  • 6[3]Maeda T,Matsunma A,Kawane T,et al.Simvastatin promotes osteoblast differentiation and mineralizationin in MC3T3-E1 cells.Biochem Biophys Res Commun,2001,280:874 -877.
  • 7[6]Woo J,Kasai S,Stern P,et al.Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts.J Bone Miner Res,2000,15:650-652.
  • 8[7]Montagnani A,Gonnelli S,Cepollaro C,et al.Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic post menopausal women:a year longitudinal stuidy.Bone,2003,32:427-433.
  • 9[8]Chan KA,Andrade SE,Boles M,et al.Inhibitors of hydroxylmethylglutaryl-coenzyme A reductase and risk of fracture a mong older women.Lancet,2000,355:2185 -2188.
  • 10[9]Wang PS,Solomon DH,Mogun H,et al.HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.JAMA,2000,283:3211-3216.

共引文献37

同被引文献145

  • 1刘力生.中国高血压防治指南2010[J].中国医学前沿杂志(电子版),2011,3(5):42-93. 被引量:1225
  • 2黄国良,张莹.糖尿病性骨质疏松的评价与对策[J].实用糖尿病杂志,2006,2(4):4-6. 被引量:53
  • 3邹继红,李洁,李荥娟.他汀类对2型糖尿病合并骨质疏松骨密度的影响[J].中华老年多器官疾病杂志,2006,5(4):258-260. 被引量:8
  • 4Hyder JA, Allison MA, Wong N, et al. Association of coronaryartery and aortic calcium with lumber bone density: the MESA Abdominal Aortic Calcium Study [ J ]. American Journal of Epidemiology, 2009,169 (2) : 186-194.
  • 5Sivas F, Alemdamglu E, Elverici E, et al. Serum lipid profile: its relationship with osteoporotic vertebrae fractures and bone mineral density in Turkish postmenopausal women [ J ]. Rheuma- tology international ,2009,29 ( 8 ) :885-890.
  • 6Linares GR, Xing W, Govoni KE, et al. Glutaredoxin 5 regulates osteoblast apoptosis by prote-cting against oxidative stress [ J ]. Bone,2009,44 ( 5 ) :795-804.
  • 7Tokuhara Y, Wakitani S, Oda Y, et al. Low levels of steroid- metabolizing hepatic enzyme (cyto-chrome P450 3 A ) activity may elevate responsiveness to steroids and may increase risk of steroid-induced osteoporosis even with low glucoeorticoid dose [ J ]. Journal of orthopaedic science, 2009, 14 (6) :794-800.
  • 8Brodeur MR, Brissette L, Falstranlt L, et al. HDL3 reduces the association and modulates the metabolism of oxidized LDL by osteoblastic cells: a protection against cell death [ J ]. Journal of Cellular Biochemistry ,2008,105 (6) : 1374-1385.
  • 9Li Y, Dong JB, Wu MP. Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice [ J ]. European Journal of Pharmacology, 2008,590 ( 1-3 ) : 417-422.
  • 10Trimpou P, Oden A, Simonsson T, et al. High serum total cholesterol is a long-term cause of osteoporotic fracture [ J ]. Osteoporosis international, 2011,22 ( 5 ) : 1615-1620.

引证文献13

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部